Analyst Recommendations

Jefferies analyst issues UNDERPERFORM recommendation for UL on January 7, 2026 12:11AM ET. The previous analyst recommendation was Underperform.UL was trading at $64.48 at issue of the analyst...

January 6, 2026   UL -2.27%

Deutsche Bank analyst issues BUY recommendation for GMAB on January 6, 2026 08:07PM ET. The previous analyst recommendation was Buy.GMAB was trading at $33.1 at issue of the...

January 6, 2026   GMAB 2.63%

Morgan Stanley analyst issues OVERWEIGHT recommendation for TTE on January 6, 2026 08:45PM ET. The previous analyst recommendation was Overweight.TTE was trading at $63.43 at issue of the...

January 6, 2026   TTE -2.33%

Barclays analyst issues OVERWEIGHT recommendation for AZN on January 6, 2026 06:35PM ET. The previous analyst recommendation was Overweight.AZN was trading at $94.42 at issue of the analyst...

January 6, 2026   AZN -0.16%

Barclays analyst issues OVERWEIGHT recommendation for GMAB on January 6, 2026 06:37PM ET. The previous analyst recommendation was Overweight.GMAB was trading at $33.0601 at issue of the analyst...

January 6, 2026   GMAB 2.63%

Barclays analyst issues OVERWEIGHT recommendation for ARGX on January 6, 2026 06:33PM ET. The previous analyst recommendation was Overweight.ARGX was trading at $805.57 at issue of the analyst...

January 6, 2026   ARGX 1.57%

Morgan Stanley analyst issues OVERWEIGHT recommendation for MT on January 6, 2026 05:26PM ET. The previous analyst recommendation was Overweight.MT was trading at $47.925 at issue of the...

January 6, 2026   MT -4.90%

Barclays analyst issues UNDERWEIGHT recommendation for GSK on January 6, 2026 04:50PM ET. The previous analyst recommendation was Equal-Weight.GSK was trading at $50.52 at issue of the analyst...

January 6, 2026   GSK -0.45%

Jefferies analyst issues BUY recommendation for TEVA on January 6, 2026 12:37PM ET. The previous analyst recommendation was Buy.TEVA was trading at $31 at issue of the analyst...

January 6, 2026   TEVA -1.32%

Morgan Stanley analyst issues OVERWEIGHT recommendation for BLTE on January 6, 2026 10:00AM ET. BLTE was trading at $159.42 at issue of the analyst recommendation.The overall analyst consensus...

January 6, 2026   BLTE 7.34%